Q3 Review| Laurus Labs Growth Strategies For Coming Quarters

#LaurusLabs' profit jumps 32% year-on-year on demand for drug ingredients. Revenues too surge 50%.
CEO Dr. Satyanarayana Chava talks about the company's growth plans in the coming quarters. #Q3WithBQ #BQLive